Evidence map›Paper›PMID 41958630›Full record

ArticleJMA journal2026

Rethinking Local Cancer Overscreening in Japan: A Path toward Organized Screening.

Masanari Minamitani

Abstract read
In one paragraph

Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Masanari MinamitaniDepartment of Radiology, The University of Tokyo Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japan's cancer screening programs have expanded widely in recent decades, with local governments and workplaces offering screenings beyond national recommendations. Although this flexibility has improved access to screening, it has also contributed to overscreening and the practice of conducting tests beyond evidence-based age ranges, intervals, and methods. The underlying principles of organized screening, which emphasize evidence-based methods and quality assurance, have often been overshadowed by administrative and institutional momentum rather than by deliberate, evidence-based planning. In 2024, Miyazaki City initiated a comprehensive review of its cancer screening system under the new medical leadership. The process identified several deviations from national guidelines in target populations and screening methods, leading to a reform policy that discontinued non-evidence-based tests, such as the ABC method (a combination of serum pepsinogen and Helicobacter pylori antibody testing) for gastric cancer, breast ultrasound, and prostate-specific antigen testing. Although implementation is ongoing, this initiative demonstrates how municipalities can begin realigning screening practices with scientific standards. The Japanese case, exemplified by Miyazaki City's initiative, highlights the importance of local leadership and an organizational understanding of the principles of organized screening. Reforming overscreening requires sustained collaboration between policymakers, healthcare providers, and citizens to balance accessibility with evidence-based practices.

Indexed as

cancer screeningevidence-based policyJapanorganized screeningoverscreening

Identifiers

PMID41958630
PMCPMC13058703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.